CN102949571B - 一种治疗慢性骨髓炎的药物 - Google Patents
一种治疗慢性骨髓炎的药物 Download PDFInfo
- Publication number
- CN102949571B CN102949571B CN201210482740.4A CN201210482740A CN102949571B CN 102949571 B CN102949571 B CN 102949571B CN 201210482740 A CN201210482740 A CN 201210482740A CN 102949571 B CN102949571 B CN 102949571B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicine
- cortex
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 206010031256 Osteomyelitis chronic Diseases 0.000 title claims abstract description 16
- 229940079593 drug Drugs 0.000 title description 5
- 210000003038 endothelium Anatomy 0.000 claims abstract description 15
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- 241001180876 Saposhnikovia Species 0.000 claims abstract description 7
- 239000000843 powder Substances 0.000 claims description 18
- 241000237636 Pheretima Species 0.000 claims description 14
- 241001057584 Myrrha Species 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 241000605447 Anemarrhena Species 0.000 claims description 6
- 208000001840 Dandruff Diseases 0.000 claims description 6
- 241000405414 Rehmannia Species 0.000 claims description 6
- 241000207929 Scutellaria Species 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 238000012545 processing Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 35
- 210000004369 blood Anatomy 0.000 abstract description 31
- 239000008280 blood Substances 0.000 abstract description 31
- 210000000988 bone and bone Anatomy 0.000 abstract description 26
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 15
- 201000010099 disease Diseases 0.000 abstract description 14
- 230000008901 benefit Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 238000012795 verification Methods 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 206010067484 Adverse reaction Diseases 0.000 abstract 1
- 244000189799 Asimina triloba Species 0.000 abstract 1
- 235000006264 Asimina triloba Nutrition 0.000 abstract 1
- 244000248539 Asparagus cochinchinensis Species 0.000 abstract 1
- 235000009292 Asparagus cochinchinensis Nutrition 0.000 abstract 1
- 235000009467 Carica papaya Nutrition 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 244000301850 Cupressus sempervirens Species 0.000 abstract 1
- 241000488974 Loranthus Species 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000004534 Scutellaria baicalensis Species 0.000 abstract 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 abstract 1
- 240000008042 Zea mays Species 0.000 abstract 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 abstract 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 abstract 1
- 230000006838 adverse reaction Effects 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- 235000005822 corn Nutrition 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 24
- 210000003734 kidney Anatomy 0.000 description 24
- 230000036407 pain Effects 0.000 description 24
- 210000004185 liver Anatomy 0.000 description 19
- 210000003205 muscle Anatomy 0.000 description 15
- 206010007247 Carbuncle Diseases 0.000 description 14
- 210000004072 lung Anatomy 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 12
- 238000012790 confirmation Methods 0.000 description 11
- 230000001717 pathogenic effect Effects 0.000 description 11
- 210000002784 stomach Anatomy 0.000 description 11
- 230000008961 swelling Effects 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 9
- 206010061218 Inflammation Diseases 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 208000006820 Arthralgia Diseases 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 7
- 241000411851 herbal medicine Species 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 230000035922 thirst Effects 0.000 description 7
- 206010010904 Convulsion Diseases 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 208000002173 dizziness Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 230000008736 traumatic injury Effects 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 210000003932 urinary bladder Anatomy 0.000 description 6
- 206010021118 Hypotonia Diseases 0.000 description 5
- 206010030113 Oedema Diseases 0.000 description 5
- 206010031252 Osteomyelitis Diseases 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 206010047700 Vomiting Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000001154 acute effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 208000002399 aphthous stomatitis Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 210000003414 extremity Anatomy 0.000 description 5
- 208000017561 flaccidity Diseases 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 231100000862 numbness Toxicity 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 238000010791 quenching Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 208000015220 Febrile disease Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010067171 Regurgitation Diseases 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 206010000269 abscess Diseases 0.000 description 4
- 239000003146 anticoagulant agent Substances 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000001780 epistaxis Diseases 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 239000002435 venom Substances 0.000 description 4
- 231100000611 venom Toxicity 0.000 description 4
- 210000001048 venom Anatomy 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 206010031253 Osteomyelitis acute Diseases 0.000 description 3
- 206010040943 Skin Ulcer Diseases 0.000 description 3
- 241000405217 Viola <butterfly> Species 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 201000001881 impotence Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 239000002398 materia medica Substances 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 231100000019 skin ulcer Toxicity 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 2
- 206010007882 Cellulitis Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000010228 Erectile Dysfunction Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 208000007565 gingivitis Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- -1 lipid peroxide Chemical class 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 235000019615 sensations Nutrition 0.000 description 2
- 201000009890 sinusitis Diseases 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 201000002327 urinary tract obstruction Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- ACTOXUHEUCPTEW-BWHGAVFKSA-N 2-[(4r,5s,6s,7r,9r,10r,11e,13e,16r)-6-[(2s,3r,4r,5s,6r)-5-[(2s,4r,5s,6s)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2s,5s,6r)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-o Chemical compound O([C@H]1/C=C/C=C/C[C@@H](C)OC(=O)C[C@@H](O)[C@@H]([C@H]([C@@H](CC=O)C[C@H]1C)O[C@H]1[C@@H]([C@H]([C@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@](C)(O)C2)[C@@H](C)O1)N(C)C)O)OC)[C@@H]1CC[C@H](N(C)C)[C@@H](C)O1 ACTOXUHEUCPTEW-BWHGAVFKSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 235000010894 Artemisia argyi Nutrition 0.000 description 1
- 206010003225 Arteriospasm coronary Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000002381 Brain Hypoxia Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 240000004528 Catalpa ovata Species 0.000 description 1
- 235000010005 Catalpa ovata Nutrition 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 description 1
- 108090000746 Chymosin Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020601 Hyperchlorhydria Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019914 Mental Fatigue Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 description 1
- 208000000592 Nasal Polyps Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- MAYJEFRPIKEYBL-OASIGRBWSA-N Obacunone Chemical compound C=1([C@@H]2OC(=O)[C@H]3O[C@@]43[C@]3(C)C(=O)C[C@H]5C(C)(C)OC(=O)C=C[C@]5(C)[C@H]3CC[C@]42C)C=COC=1 MAYJEFRPIKEYBL-OASIGRBWSA-N 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010031149 Osteitis Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 239000004187 Spiramycin Substances 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 1
- 208000006568 Urinary Bladder Calculi Diseases 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 238000002266 amputation Methods 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 244000030166 artemisia Species 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 208000018339 bone inflammation disease Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000009172 bursting Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- AMSCMASJCYVAIF-QCVMBYIASA-N carpaine Chemical compound O([C@H]1CC[C@@H](CCCCCCCC(=O)O2)N[C@H]1C)C(=O)CCCCCCC[C@H]1N[C@@H](C)[C@@H]2CC1 AMSCMASJCYVAIF-QCVMBYIASA-N 0.000 description 1
- HXFUVYFNBRBBPM-UHFFFAOYSA-N carpaine Natural products CC1(CCCCCCCC(=O)O1)C2CCCN2 HXFUVYFNBRBBPM-UHFFFAOYSA-N 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 229940080701 chymosin Drugs 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 229960001200 clindamycin hydrochloride Drugs 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 229960004273 floxacillin Drugs 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 231100000003 human carcinogen Toxicity 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229930013032 isoflavonoid Natural products 0.000 description 1
- 150000003817 isoflavonoid derivatives Chemical class 0.000 description 1
- 235000012891 isoflavonoids Nutrition 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- XKLJHFLUAHKGGU-UHFFFAOYSA-N nitrous amide Chemical compound ON=N XKLJHFLUAHKGGU-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- VSLDMVSILHVDSR-UHFFFAOYSA-N obacunone Natural products CC1(C)OC(=O)C=CC2(C)C1CC(=O)C3(C)C2CCC4(C)C(OC(=O)C5OC345)c6occc6 VSLDMVSILHVDSR-UHFFFAOYSA-N 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 208000023482 precordial pain Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229960001294 spiramycin Drugs 0.000 description 1
- 229930191512 spiramycin Natural products 0.000 description 1
- 235000019372 spiramycin Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002889 sympathetic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000002303 tibia Anatomy 0.000 description 1
- 229960005053 tinidazole Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 210000000623 ulna Anatomy 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗慢性骨髓炎的药物,属中药领域。本发明药物有效成分的原料组成及重量份数为:天冬40~65份、熟地40~60份、知母40~55份、紫花地丁40~55份、桑寄生40~50份、干葛40~50份、苍术35~55份、枸杞子35~50份、木瓜30~50份、没药25~45份、黄柏25~45份、防风25~40份、白芷25~40份、乌贼骨20~40份、地龙15~35份、黄芩15~35份、鸡内金15~30份、冰片10~15份、肉桂5~10份、鹿茸5~10份。本发明采用中药,选材配伍精良,炮制各依药性,以求标本兼治之功,通血理气,化瘀散毒;吸收效果好,疗效显著,安全可靠,无毒副作用及临床不良反应,经临床验证,对慢性骨髓炎有极好的疗效。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种治疗慢性骨髓炎的药物。
背景技术
骨髓炎为一种骨的感染和破坏,由需氧或厌氧菌、分枝杆菌、真菌引起。骨髓炎好发于椎骨、糖尿病患者的足部、或由于外伤或手术引起的穿透性骨损伤部位,儿童最常见部位为血供良好的长骨,如胫骨或股骨的干骺端。
中医称之为附骨疽,其成因一般认为是“跌打损伤,气滞血瘀,感染毒邪,瘀毒搏结,深扰骨髓,腐败化脓而成”,通常又分为急性骨髓炎和慢性骨髓炎。急性骨髓炎是化脓菌由身体其它部位的感染灶进入血流传播并定位于骨组织而引起的炎症,可通过西药紧急注射抗菌消炎抗感染处理,而慢性化脓性骨髓炎并无时间限定,在小儿,大都由急性化脓性骨髓炎演变而来;在成人,其多为创伤后继发感染而形成。有的病例因细菌毒力低,一开始便呈慢性骨髓炎表现。慢性化脓性骨髓炎依其临床表现和X线征象,一般不难诊断。
目前临床上对骨髓炎的治疗,通用的方法有川岛式持续冲洗术、死骨保留及再植入、Papineau手术法、骨剥皮手术法、微创外固定技术,以及其它常规外科手术,比如穿刺吸引术、开窗引流术、死骨取出术、消灭骨空洞术、截肢术、大块病骨切除术、病人留置药物链法等,这些手术治疗手段根据病情的具体需要而实施,但无论是采用哪种手术方法,都意味着骨髓炎症已经发展到较为严重的程度。
中医理论认为,附骨疽的发生有其内在的致病机理,无论是跌打损伤引发的炎症,还是致病菌感染,实际都是导致机体阴阳失和、腠理失调、正邪失衡,针对性的诊治则是固本清源、扶正祛邪,使气理平和,筋脉疏通。
现有的针对骨髓炎的中药方剂,往往是针对某一特定经脉调配的,并不具备广泛的骨髓炎防治效果,目前尤其需要一种能防治多处经络附骨疽的验方。
发明内容
本发明提供了一种治疗慢性骨髓炎的药物,具有滋阴润燥,清肺降火,通经疏络,消炎抗菌,蚀疽破痈,生肌填髓之功效,对各种原因引起的慢性骨髓炎具有很好的疗效。
为实现上述目的,本发明的技术方案实施如下:
一种治疗慢性骨髓炎的药物,制成所述药物有效成分的原料组成及重量份数为:
天冬40~65份 熟地40~60份 知母40~55份 紫花地丁40~55份
桑寄生40~50份 干葛40~50份 苍术35~55份 枸杞子35~50份
木瓜30~50份 没药25~45份 黄柏25~45份 防风25~40份
白芷25~40份 乌贼骨20~40份 地龙15~35份 黄芩15~35份
鸡内金15~30份 冰片10~15份 肉桂5~10份 鹿茸5~10份
制成所述药物有效成分的原料组成及重量份数为:
天冬45~60份 熟地45~55份 知母45~50份 紫花地丁45~50份
桑寄生42~48份 干葛42~48份 苍术40~50份 枸杞子38~45份
木瓜35~45份 没药30~40份 黄柏30~40份 防风28~35份
白芷28~35份 乌贼骨25~35份 地龙20~30份 黄芩20~30份
鸡内金20~25份 冰片10~13份 肉桂6~8份 鹿茸6~8份
制成所述药物有效成分的原料组成及重量份数为:
天冬52份 熟地46份 知母48份 紫花地丁48份
桑寄生45份 干葛45份 苍术45份 枸杞子42份
木瓜40份 没药35份 黄柏35份 防风32份
白芷32份 乌贼骨30份 地龙25份 黄芩25份
鸡内金22份 冰片11份 肉桂6份 鹿茸6份
一种治疗慢性骨髓炎的药物的制备方法,包括以下工艺步骤:
(1)将鸡内金洗净晾干,文火略炒后研末,过120目细粉,备用。
(2)将天冬、熟地、知母、紫花地丁、桑寄生、干葛、苍术、防风、白芷、地龙、冰片、肉桂和鹿茸吹皮去屑,研末,过100目细粉,备用。
(3)将枸杞子、木瓜、没药、黄柏、乌贼骨、黄芩加入容器中,加入六味药总重量8倍量的水,提取3~4小时,过滤,取药液;在剩余的残渣中再加入4倍量的水,提取1~2小时,过滤,取药液;合并两次药液,浓缩成60℃下相对密度1.22~1.24的稠膏。
(4)将步骤(1)和步骤(2)中所得细粉加入步骤(3)制得的稠膏中混合均匀,于50~60℃干燥后,粉碎成120目的细粉,装入胶囊中灭菌消毒制得胶囊剂产品。
本发明所用中药的药性如下:
天冬:味甘;苦;性寒;入肺;肾经。滋阴润燥;清肺降火。燥热咳嗽;阴虚劳嗽;热病伤阴;内热消渴;肠燥便秘;咽喉肿痛。《本草汇言》载:“除偏痹、强骨髓者,因肺热成痿,肾热髓枯,筋槁不荣而成偏痹者也。”现代医学研究证实,天门冬对炭疽杆菌、甲型及乙型溶血性链球菌、白喉杆菌、类白喉杆菌、肺炎双球菌、金黄色葡萄球菌、柠檬色葡萄球菌、白色葡萄球菌及枯草杆菌均有不同程度的抑菌作用,对急性淋巴细胞型白血病、慢性粒细胞型白血病及急性单核细胞型白血病患者白细胞的脱氢酶有一定的抑制作用,并能抑制急性淋巴细胞型白血病患者白细胞的呼吸。
熟地:味甘;性温;归肝;肾经。补血滋润;益精填髓。主治血虎萎黄;眩晕心悸;肝肾阴亏;腰膝酸软;肾虚喘促。《本草汇言》载:“久病阴伤,新产血败,在所必需者也。”现代医学研究证实,熟地可增强GSH-Px活性和降低血清中LPO的含量,提高血浆AD浓度,与骨髓造血系统亦有密切相关的作用。
知母:味苦;性寒;入肺;胃;肾经。清热泻火;滋阴润燥;止渴除烦。主治温热病;高热烦渴;咳嗽气喘;燥咳;便秘;骨蒸潮热;虚烦不眠;消渴淋浊。《药性论》载:“主治心烦躁闷,骨热劳往来,生产后蓐劳,肾气劳,憎寒虚损,患人虚而口干,加而用之。”现代医学研究证实,知母能抑制肝脏对皮质醇的分解代谢,对多种病原微生物有抑制作用,此外还有降低血糖、抑制肿瘤生长和血小板聚集的作用。
紫花地丁:味苦;辛;性寒;归心;肝经。清热解毒;凉血消肿。主治黄疸、痢疾、乳腺炎、目赤肿痛、咽炎、跌打损伤、痈肿、疔疮肿毒、痈疽发背、丹毒、毒蛇咬伤。《本经逢原》载:“治疔肿恶疮,兼疗痈疽发背,无名肿毒。”现代医学研究证实,紫花地丁在试管内有抑制结核杆菌生长的作用,其醇提物对钩端螺旋体有抑制作用,对堇色毛癣菌有抑制作用,此外尚有清热、消肿、消炎等作用。
桑寄生:味苦;甘;性平;入肝;肾经。补肝肾;强筋骨;祛风湿;安胎。主治腰膝酸痛;筋骨痿弱;肢体偏枯;风湿痹痛;头晕目眩;胎动不安,崩漏下血。《本草求真》载:“缘肾主骨,发主血,苦人肾,肾得补则筋骨有力,不致屡痔而酸感矣。甘补血,血得补则发受其灌荫而不桔脱落矣。故凡内而腰痛、筋骨笃疾、胎堕,外而金疮、肌肤风湿。”现代医学研究证实,桑寄生有降压、抗心律失常、增加冠脉流量、改善冠脉循环、增强心脏收缩力、降低心肌耗氧、抑制血小板聚集,抗血栓形成、改善微循环、抗肿瘤作用、治疗肝炎等诸多功效。
干葛:味甘;辛;性平。入脾;胃;肺;膀胱经。解肌退热;发表透诊;生津止渴;升阳止泻。主治外感发热;头项强痛;麻疹初起;疹出不畅;温病口渴;消渴病;泄泻;痢疾;高血压;冠心病。《本草经疏》载:“解散阳明温病热邪之要药也,故主消渴,身大热,热壅胸隔作呕吐。发散而升,风药之性也,放主诸痹。”现代医学研究表明,葛根中富含葛根素、多达13种异黄酮类,干葛中的异黄酮类化合物葛根素对高血压、高血脂、高血糖和心脑血管疾病有一定疗效。
苍术:味辛;苦;性温。归脾;胃;肝经。燥湿健脾;祛风湿;明目。主治湿困脾胃;倦怠嗜卧;胞痞腹胀;食欲不振;呕吐泄泻;痰饮;湿肿;表证夹湿;头身重痛;痹证温性;肢节酸痛重着;痿襞;夜盲。《玉楸药解》载:“燥土利水,泄饮消痰,行瘀,开郁,去漏,化癖,除症,理吞酸去腐,辟山川瘴疠,回筋骨之痿软,清溲溺之混浊。”现代医学研究证实,苍术所含挥发油有驱风健胃作用,所含苦味也有健胃、促进食欲的作用,有明显的抗副交感神经介质乙酰胆碱引起的肠痉挛,对心脏有轻微的抑制作用,对血管有轻微的扩张作用,还有使脊髓反射亢进之功效。
枸杞子:味甘;性平。归肝;肾;肺经。养肝;滋肾;润肺。主治肝肾亏虚;头晕目眩;目视一清;腰膝酸软;阳痿贵精;虚劳咳嗽;消渴引饮。《本草正》载:“明耳目,添精固髓,健骨强筋,善补劳伤,尤止消渴。”现代医学研究证实,枸杞子可调节机体免疫功能、能有效抑制肿瘤生长和细胞突变、具有延缓衰老、抗脂肪肝、调节血脂和血糖、促进造血功能等方面的作用。
木瓜:味酸;性温。入肝;肺;肾;脾经。舒筋活络;和胃化湿。主治风湿痹痛,肢体酸重,筋脉拘挛,吐泻转筋,脚气水肿。《本草正》载:“疗腰膝无力,脚气,引经所不可缺,气滞能和,气脱能固。以能平胃,故除呕逆、霍乱转筋,降痰,去湿,行水。”现代医学研究证实,木瓜含番木瓜碱、木瓜蛋白酶、凝乳酶、胡萝卜素等;并富含十七种以上氨基酸及多种营养元素,具有护肝降酶、抗炎抑菌、降低血脂等作用,还有阻止人体致癌物质亚硝胺合成的功效。
没药:味苦;辛;性平;入肝;脾;心;肾经。《本草经疏》载:“凡骨节痛与夫胸腹胁肋痛”,主治跌打损伤、金疮、筋骨、心腹诸痛、症瘕、痈疽肿痛,散血去瘀,消肿止痛。现代医学研究证实,似荷尔蒙、可调节甲状腺,具有强力消炎、杀菌、止痛以及对抗病毒的效果。
黄柏:味苦;性寒。入肾;膀胱经。清热燥湿;泻火解毒。主治湿热痢疾、泄泻、黄疸;梦遗、淋浊、带下;骨蒸劳热;以及口舌生疮;目赤肿痛;痈疽疮毒;皮肤湿疹。《药品化义》载:“降火能自顶至踵,沦肤彻髓,无不周到,专泻肾与膀胱之火。”现代医学研究证实,黄柏含小蘖碱、黄柏酮等主要成分,有抗菌、收敛、消炎的作用,对各种皮肤湿毒、疮疡等症状,功效良好。
防风:味辛;微甘;性微温。归肺;膀胱;肝;脾经。发表;祛风;胜湿;止痛。主治风寒感冒;感冒夹湿;头痛;昏眩;寒湿腹痛;泄泻;风湿痹痛;四肢拘挛;破伤风;目赤;疮疡;疝瘕;疥癣;风疹。《日华子本草》载:“治三十六般风,男子一切劳劣,补中益神,风赤眼,止泪及瘫缓,通利五脏关脉,五劳七伤,羸损盗汗,心烦体重,能安神定志,匀气脉。”现代医学研究证实,防风能显著提高急性脑缺氧的耐缺氧能力,显著抑制体外诱发的脂质过氧化物的形成,具有抗氧化活性,对神经细胞起保护作用。
白芷:味辛;性温。归肺;脾;胃经。祛风除湿;通窃止痛;消肿排脓。主治感冒头痛;眉棱骨痛;牙痛;鼻塞;鼻渊;湿胜久泻;妇女白带;痈疽疮疡;毒蛇咬伤。《纲目》载:“治鼻渊、鼻衄、齿痛、眉棱骨痛,大肠风秘,小便出血,妇人血风眩运,翻胃吐食;解砒毒,蛇伤,刀箭金疮。”现代医学研究关,白芷对中枢神经系统有兴奋作用,可抑制肝药物代谢酶系统,此外还具有解热镇痛、抗炎、抗菌、降血压等功效,能活化交感系统激素,抑制脂肪合成。
乌贼骨:味咸;涩;性温。入肝;肾经。收敛止血;固精止带;制酸止痛;收湿敛疮。主治吐血;呕血;崩漏;便血;衄血;创伤出血;肾虚遗精滑精,赤白带下,胃痛嘈杂;嗳气泛酸;湿疹溃疡。《本草经疏》载“:入肝胆,舒营气,故亦主之。温而燥湿,故又主疮多脓汁也。”现代医学研究证实,乌贼骨可促进溃疡面炎症吸收,阻止出血,减轻局部疼痛,有明显促进骨缺损修复作用,此外还有抗辐射和抗肿瘤之功效。
地龙:味咸;性寒。归肝;脾;膀胱经。清势止痉;平肝熄风;通经活络;平喘利尿。主治热病发热狂燥;惊痫抽搐;肝阳头痛;中风偏瘫;风湿痹痛;肺热喘咳;小便不通。《本草纲目》载:“性寒而下行,性寒故能解诸热疾,下行故能利小便,治足疾而通经络也。”“主伤寒疟疾,大热狂烦,及大人小儿小便不通,急慢惊风,历节风痛。”现代医学研究证明,地龙含有地龙素、地龙解热素、维生素B族复合体等成分,具有利尿、镇痛、平喘、降压、解热、抗惊厥等作用。
黄芩:味辛;苦;性寒。归肺;肝;肾经。清热解毒;散瘀止血;利尿消肿。主治热毒痈肿;咽喉疼痛;肺痈;肠痈;瘰疬;毒蛇咬伤;跌打损伤;吐血;衄血;血淋;水肿;腹水及癌症。《泉州本草》载:“清热,解毒,法风,散血,行气,利水,通络,破瘀,止痛。内服主血淋,吐血,衄血;外用冶毒蛇咬伤,痈疽,疔疮,无名肿毒。”现代医学研究证实,黄芩具有广谱抗菌作用,此外还有抗血小板聚集、抗凝以及降血脂的作用。
鸡内金:味甘;性平。归脾;胃;肾;膀胱经。健脾消食;涩精止遗;消癥化石。主治消化不良;饮食积滞;呕吐反胃;泄泻下痢;小儿疳积;遗精;遗尿;小便频数;泌尿系结石及胆结石;癥瘕经闭;喉痹乳蛾;牙疳口疮。《本草纲目》载:“治小儿食疟,疗大人(小便)淋漓、反胃,消酒积,主喉闭、乳蛾,一切口疮,牙疳诸疮。”现代医学临床证实,鸡内金用于治疗消化不良、慢性胃炎、胆结石、膀胱炎、膀胱结石、口腔溃疡、遗精遗尿、胃癌、肝硬化等多种疾病,有较好的疗效。
冰片:味辛;苦;性凉。入心;肺经。开窍醒神;散热止痛;明目去翳。主治中风口噤;热病神昏;惊痫痰迷;气闭耳聋;目赤翳膜;喉痹;口疮;痈肿;痔疮;蛲虫病。《本草正》载:“味微甘大辛,敷用者其凉如冰,而气雄力锐。本非热,阳中有阴也。善散气,散血,散火,散滞,通窍,辟恶,逐心腹邪气。”现代医学研究证实,冰片可抑制或杀灭金黄色葡萄球菌、乙型溶菌性链球菌等5种常见细菌,冰片学能有效促进其他药物透皮吸收的作用,有利于冠状痉挛的防治,可减轻缺血所致的心肌损伤。
肉桂:味辛;苦;性热。入肾;脾;心;肝经。补火助阳;引火归源;散寒止痛;温经通脉。主治肾阳不足;命门火畏寒肢冷;腰膝酸软;阳痿遗精;小便不利或频数;短气喘促;浮肿尿少诸证;命门火衰;火不归源;戴阳;格阳;及上热下寒;面赤足冷;头晕耳鸣;口舌糜破;脾肾虚寒;脘腹冷痛;食减便溏;肾虚腰痛;寒湿痹痛;寒疝疼痛;宫冷不孕;痛经经闭;产后瘀滞腹痛;阴疽流注;或虚寒痈疡脓成不溃;或溃后不敛。《药性论》载:“主治九种心痛,杀三虫,主破血,通利月闭,治软脚,痹、不仁,胞衣不下,除咳逆,结气、拥痹,止腹内冷气,痛不可忍,主下痢,鼻息肉。杀草木毒。”现代医学研究证实,肉桂含有肉桂醛、醋酸肉桂酯、醋酸苯基丙酪等成分,具有芳香健胃、解热镇痛、抗菌消炎的作用。
鹿茸:味甘;咸;性温。入肾;肝经。壮肾阳;益精血;强筋骨;托疮毒。主治肾阳虚衰;阳痿滑精;宫冷不孕;虚劳赢瘦;神疲畏寒;眩晕;耳鸣耳聋;腰背酸痛;筋骨痿软;小儿五迟;女子崩漏带下;阴疽。《本草经疏》载:“疗虚劳洒洒如疟,羸瘦,四肢酸疼,腰脊痛,小便利,泄精,溺血,破留血在腹,散石淋,痈肿,骨中热,疽痒。”现代医学研究证实,鹿茸含有丰富的氨基酸、卵磷脂、维生素和微量元素,可以提高机体的细胞免疫和体液免疫功能,促进淋巴细胞的转化,具有免疫促进剂的作用,还能增加机体对外界的防御能力,调节体内的免疫平衡而避免疾病发生和促进创伤愈合、病体康复。
本发明与现有技术相比,具有以下有益效果:
本发明采用中药,选材配伍精良,炮制各依药性,以求标本兼治之功,通血理气,化瘀散毒;吸收效果好,疗效显著,安全可靠,无毒副作用及临床不良反应,经临床验证,对慢性骨髓炎有极好的疗效。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明药物有效成分的原料组成及重量为:
天冬60g 熟地58g 知母52g 紫花地丁52g
桑寄生48g 干葛48g 苍术45g 枸杞子46g
木瓜46g 没药42g 黄柏42g 防风38g
白芷38g 乌贼骨36g 地龙32g 黄芩32g
鸡内金28g 冰片13g 肉桂8g 鹿茸8g
本发明药物制备方法的工艺步骤为:
(1)将鸡内金洗净晾干,文火略炒后研末,过100目细粉,备用。
(2)将天冬、熟地、知母、紫花地丁、桑寄生、干葛、苍术、防风、白芷、地龙、冰片、肉桂和鹿茸吹皮去屑,研末,过100目细粉,备用。
(3)将枸杞子、木瓜、没药、黄柏、乌贼骨、黄芩加入容器中,加入六味药总重量8倍量的水,提取3~4小时,过滤,取药液;在剩余的残渣中再加入4倍量的水,提取1~2小时,过滤,取药液;合并两次药液,浓缩成60℃下相对密度1.22~1.24的稠膏。
(4)将步骤(1)和步骤(2)中所得细粉加入步骤(3)制得稠膏中混合均匀,于50~60℃干燥后,粉碎成120目的药粉,装入胶囊中灭菌消毒制得胶囊剂产品。
用法用量:每日3次,每次6~12g,饭后一小时温开水送服,9天为一个疗程,通常1~2个疗程有效,顽症需3~4个疗程。
实施例2
本发明药物有效成分的原料组成及重量为:
天冬55g 熟地50g 知母46g 紫花地丁46g
桑寄生46g 干葛48g 苍术46g 枸杞子45g
木瓜42g 没药38g 黄柏38g 防风34g
白芷35g 乌贼骨32g 地龙28g 黄芩28g
鸡内金23g 冰片12g 肉桂7g 鹿茸7g
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明药物有效成分的原料组成及重量为:
天冬52g 熟地46g 知母48g 紫花地丁48g
桑寄生45g 干葛45g 苍术45g 枸杞子42g
木瓜40g 没药35g 黄柏35g 防风32g
白芷32g 乌贼骨30g 地龙25g 黄芩25g
鸡内金22g 冰片11g 肉桂6g 鹿茸6g
本实施例的药物制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择
选择我院或外院确诊的骨髓炎患者67例临床观察,病人随机分成两组,治疗组34例,其中男性23例,女性11例,年龄27~66岁,平均年龄43.6岁,病程最短者6个月,最长者17年,平均7.8年。对照组33例,其中男性21例,女性12例,年龄26~71岁,平均年龄46.2岁,病程最短者7个月,最长者14年,平均6.3年。两组资历基本一致,无显著差异,具有可比性。
2、治疗组患者服用本发明药物,成人每日3次,每次6~12g,饭后一小时内温开水送服,9天为一个疗程,通常1~2个疗程有效,顽症需3~4个疗程。对照组随机选择下述样药品之一,严格按照药品说明书服用:
磷霉素钙胶囊、强力阿莫仙、胜艾、氟氯西林钠胶囊、阿莫西林克拉维酸钾片(7:1)、螺旋霉素片、骨炎灵片、乐净、康尼、头孢氨苄片、安奇、盐酸克林霉素胶囊、替硝唑片
3、疗效判定:
(1)痊愈:患部肿胀消失,压痛感消失,全身发冷发热症状消退,X线片显示骨质破坏消退。
(2)好转:患部肿胀减轻,压痛感减轻,全身发冷发热症状消退,X线片显示骨质破坏情况好转。
(3)无效:症状及X线片显示骨质破坏情况同治疗前无明显变化。
4、结果
服用本发明药物的治疗组中,治愈21例,好转9例,无效4例,治愈率62%,总有效率88%。
对照组中治愈2例,好转19例,无效12例,治愈率6%,总有效率64%。
以上结果显示,治疗组的治愈率和总有效率明显高于对照组。
典型病例举例:
1、陈××,男,61岁,农民。患者自述臂、腿关节肿痛,左腿膝关节下部红肿,稍有破溃即引起经久不愈的溃疡,破疮流脓,压痛感强烈,长期不愈合。多次尝试消炎抗菌药物治疗,反复发作,曾于2010年掉出小块死骨,关节肿大增粗,已有畸形症状,行走坐卧已失去自主能力。经服用本发明胶囊2个疗程后,肿痛症状有所缓解,疮口流脓现象减轻,压痛感趋于和缓;继续服用本发明胶囊3个疗程后,疮口生肌,关节仍有肿大现象,但压痛感基本消失;目前正在进行第7个疗程的治疗。
2、国××,女,28岁,中学教师。该患者因在学校运动会上意外摔伤,致使肘关节红肿疼痛,经久不愈。后经X线片诊断为骨膜下脓肿,软组织脓肿。经过一段时间的抗菌治疗,效果不显著,疼痛感加剧。来我院诊疗时,发现有瘘孔出现的可能性,遂在其继续静脉注射抗菌消炎的基础上,辅以本发明胶囊,每日三次,每次口服8g,经过2个疗程的治疗,X线片显示其骨膜下脓肿和软组织脓肿已全部消失,红肿现象消退,疼痛感消失,随访半年,未复发。
Claims (4)
1.一种治疗慢性骨髓炎的药物,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
天冬40~65份 熟地40~60份 知母40~55份 紫地花丁40~55份
桑寄生40~50份 干葛40~50份 苍术35~55份 枸杞子35~50份
木瓜30~50份 没药25~45份 黄柏25~45份 防风25~40份
白芷25~40份 乌贼骨20~40份 地龙15~35份 黄芩15~35份
鸡内金15~30份 冰片10~15份 肉桂5~10份 鹿茸5~10份 。
2.根据权利要求1所述的一种治疗慢性骨髓炎的药物,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
天冬45~60份 熟地45~55份 知母45~50份 紫地花丁45~50份
桑寄生42~48份 干葛42~48份 苍术40~50份 枸杞子38~45份
木瓜35~45份 没药30~40份 黄柏30~40份 防风28~35份
白芷28~35份 乌贼骨25~35份 地龙20~30份 黄芩20~30份
鸡内金20~25份 冰片10~13份 肉桂6~8份 鹿茸6~8份。
3.根据权利要求1所述的一种治疗慢性骨髓炎的药物,其特征在于:制成所述药物有效成分的原料组成及重量份数为:
天冬52份 熟地46份 知母48份 紫地花丁48份
桑寄生45份 干葛45份 苍术45份 枸杞子42份
木瓜40份 没药35份 黄柏35份 防风32份
白芷32份 乌贼骨30份 地龙25份 黄芩25份
鸡内金22份 冰片11份 肉桂6份 鹿茸6份。
4.一种如权利要求1-3任一项所述的治疗慢性骨髓炎的药物的制备方法,其特征在于:包括以下工艺步骤:
(1)将鸡内金洗净晾干,文火略炒后研末,过120目细粉,备用;
(2)将天冬、熟地、知母、紫地花丁、桑寄生、干葛、苍术、防风、白芷、地龙、冰片、肉桂和鹿茸吹皮去屑,研末,过100目细粉,备用;
(3)将枸杞子、木瓜、没药、黄柏、乌贼骨、黄芩加入容器中,加入六味药
总重量8倍量的水,提取3~4小时,过滤,取药液;在剩余的残渣中再加入4倍量的水,提取1~2小时,过滤,取药液;合并两次药液,浓缩成60℃下相对密度1.22~1.24的稠膏;
(4)将步骤(1)和步骤(2)中所得细粉加入步骤(3)制得稠膏中混合均匀,于50~60℃干燥后,粉碎成120目的细粉,装入胶囊中灭菌消毒制得胶囊剂产品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210482740.4A CN102949571B (zh) | 2012-11-25 | 2012-11-25 | 一种治疗慢性骨髓炎的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201210482740.4A CN102949571B (zh) | 2012-11-25 | 2012-11-25 | 一种治疗慢性骨髓炎的药物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102949571A CN102949571A (zh) | 2013-03-06 |
| CN102949571B true CN102949571B (zh) | 2014-04-16 |
Family
ID=47759330
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201210482740.4A Expired - Fee Related CN102949571B (zh) | 2012-11-25 | 2012-11-25 | 一种治疗慢性骨髓炎的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102949571B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104623445A (zh) * | 2015-02-28 | 2015-05-20 | 张阳 | 一种治疗肝肾亏虚型外伤性慢性骨髓炎的中药及制备方法 |
| CN105125854A (zh) * | 2015-09-08 | 2015-12-09 | 黄平县花院青山绿水养殖专业合作社 | 一种治疗慢性骨髓炎的中药组合物 |
| CN112516216A (zh) * | 2019-08-28 | 2021-03-19 | 海南广之生健康养生有限公司 | 一种外用养发生发的中药组合物及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101406646A (zh) * | 2008-11-26 | 2009-04-15 | 路敦祥 | 治疗关节炎的中药药酒 |
| CN102512565B (zh) * | 2011-12-19 | 2014-05-21 | 毕波 | 一种治疗肾虚腰痛的中药组合物 |
-
2012
- 2012-11-25 CN CN201210482740.4A patent/CN102949571B/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102949571A (zh) | 2013-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579774B (zh) | 一种用于治疗颈淋巴结核的中药组合物 | |
| CN104474471A (zh) | 一种治疗甲状腺的中药组合物 | |
| CN103977358A (zh) | 一种降脂护肝的口服中药 | |
| CN104524287A (zh) | 一种治疗过敏性紫癜的中药组合物及其制备方法 | |
| CN105213941A (zh) | 一种用于治疗小儿腹泻的中药组合物及其制备方法 | |
| CN102949571B (zh) | 一种治疗慢性骨髓炎的药物 | |
| CN103520655A (zh) | 一种治疗寻常型银屑病的中药组合物及其制备方法 | |
| CN104288413A (zh) | 一种治疗小儿痢疾的中药组合物、其制备方法、制剂及应用 | |
| CN104383384A (zh) | 一种治疗手足癣的中药洗液 | |
| CN104398927A (zh) | 治疗膝关节滑膜炎的中药制剂 | |
| CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
| CN105106634A (zh) | 一种治疗急性阑尾炎的中药制剂及其应用 | |
| CN100571725C (zh) | 一种治疗坐骨神经痛的中药制剂 | |
| CN103816450B (zh) | 一种治疗类风湿性关节炎的中药 | |
| CN104173646A (zh) | 治疗气血两虚所致眩晕的中药汤剂及其制备方法 | |
| CN104225256A (zh) | 一种治疗火毒内陷型烧伤的中药及制备方法 | |
| CN104666999A (zh) | 一种降血压的中药配方 | |
| CN103961658A (zh) | 一种降脂护肝的胶囊制剂 | |
| CN103751752B (zh) | 一种治疗痢疾的药物及其制备方法 | |
| CN105998781A (zh) | 一种治疗急性胃肠炎的药物组合物 | |
| CN105169348A (zh) | 一种促进胰腺切开引流术后康复的中药制剂及制备方法 | |
| CN105362944A (zh) | 一种治疗骨科扭挫伤的中药膏剂 | |
| CN105363005A (zh) | 紫荆皮中药酒 | |
| CN105288422A (zh) | 一种用于治疗腹绞痛综合征的中药制剂及制备方法 | |
| CN103638188A (zh) | 一种用于防治慢性骨髓炎的中药及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140416 Termination date: 20141125 |
|
| EXPY | Termination of patent right or utility model |